ANNA Home Page
ANNA CE Link
HDCN Home Page
HDCN Registration Link

If you dont have an Acrobat Reader installed on your computer, you may download it for free from the link below:


Contraindication of Angiotensin-Converting Enzyme (ACE) Inhibitors For Patients Receiving Therapeutic Plasma Exchanges
(Vol 35/No. 6. On-line test expires: 12/20/2010)
To receive continuing education credit, you must read the information in this article and take an on-line post test and fill out an on-line program evaluation form. The certificate will then be generated for you as a .pdf file which you can print out locally on your computer.

CE Certification by ANNA requires a handling charge that must be paid by credit card. Pricing information is available by clicking on the "Post-Test Evaluation" link below.
  DOWNLOAD TEST ARTICLE
Please download and print the PDF file below:
  AUTHOR
Kylie A. Perkins, BSN, RN, AT(ASCP)
 Kylie A. Perkins, BSN, RN, AT(ASCP), is a Clinical Nurse Coordinator, Medical University of South Carolina, Charleston, SC, and a member of ANNA’s Palmetto Chapter #203.
  OUTLINE

Therapeutic plasma exchange is a therapy in which the plasma portion of the blood is removed by a device known as a cell separator. The separator works by spinning the blood at high speed to separate the cells from the fluid and returning the remaining cells to the patient, while the plasma is discarded and substituted with replacement fluids. Common complications of plasma exchange include the occurrence of hypotensive reac - tions. This article reviews the current literature in an attempt to clarify the correlation between the use of angiotensin-converting enzyme (ACE) inhibitors and hypotensive patient reactions, as well as examines the need for policy and guideline development regarding the combined therapies, and finishes by further examining future research implications.
  GET YOUR CE CERTIFICATE
Take on-line Quiz:
  CE RELATED INFORMATION
This offering for 1.0 contact hours is being provided by the American Nephrology Nurses’ Association (ANNA), This offering for 1.0 contact hours is being provided by the American Nephrology Nurses’ Association (ANNA). ANNA is accredited as a provider of continuing nursing education (CNE) by the American Nurses Credentialing Center’s Commission on Accreditation. ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910. This CNE article meets the Nephrology Nursing Certification Commission’s (NNCC’s) continuing nursing education requirements for certification and recertification.

  EDUCATIONAL OBJECTIVES

Goal: To provide information about the correlation between the use of angiotensin-coating enzyme (ACE) inhibitors and hypotensive patient reactions.

Objectives:
1. Describe a therapeutic plasma exchange procedure.
2. Discuss relevant studies regarding the use of ACE inhibitors in the treatment of patients receiving therapeutic plasma exchanges.
3. Explain clinical implications of using ACE inhibitors for patients receiving plasma therapy.
AUTHOR DISCLOSURE STATEMENT

Kylie A. Perkins has no conflicts of interest to disclose.

 ANNA and HDCN CE POLICY STATEMENTS

The CE policy and disclosure statements of the American Nephrology Nurses' Association are given in detail on the Symposium Home Page. The CE policy statements of HDCN are listed on this page.